Synonym: (5Z,9α,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt; PGF2α−Tris
CAS Number: 38562-01-5
Empirical Formula (Hill Notation): C20H34O5 · C4H11NO3
Molecular Weight: 475.62
EC Number: 254-002-3
MDL Number: MFCD00077863
Linear Formula: C20H34O5 · C4H11NO3
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: P0424-10MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: P0424-1MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: P0424-5MG
| assay |
≥99% |
| biological source |
synthetic |
| color |
white |
| form |
powder |
| functional group |
carboxylic acid |
| |
hydroxyl |
| InChI |
1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4-,13-12+;/t15-,16+,17+,18-,19+;/m0./s1 |
| InChI key |
IYGXEHDCSOYNKY-RZHHZEQLSA-N |
| Quality Level |
200  |
| shipped in |
ambient |
| SMILES string |
NC(CO)(CO)CO.[H][C@]1(CC=C/CCCC(O)=O)[C@@H](O)C[C@@H](O)[C@]1([H])C=C[C@@H](O)CCCCC |
| solubility |
ethanol: 50 mg/mL |
| |
H2O: 1 mg/mL |
| storage temp. |
−20°C |
| Biochem/physiol Actions: |
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. |
| Biochem/physiol Actions: |
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. A positive feedback loop between endometrial PG F2α and luteal oxytocin is responsible for completion of luteolysis. |
| Biochem/physiol Actions: |
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. Also stimulates contraction of smooth muscle, such as in bronchi, with possible involvement in asthma. This effect is at least partially mediated through tachykinin release. |
| General description: |
Aqueous solutions are stable for 30 days at 2-8°C and for several months frozen at −0°C in single use aliquots. Avoid repeated freeze/thaw cycles. |
| Packaging: |
1, 5, 10 mg in glass bottle |
| Purity |
≥99% |
| Storage Temp. |
−20°C |
| UNSPSC |
12352401 |